BIOMAT Database Logo BIOMAT Database Logo

[Clinical application of an angiotensin II analogue (ii). Blood pressure changes following the infusion of 1-sarcosine. 8-isoleucine angiotensin II in various hypertensive disorders and body fluid abnormalities (author's transl)]. 1976

T Yamamoto, and T Ogihara, and Y Kumahara, and T Hata

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001826 Body Fluids Liquid components of living organisms. Body Fluid,Fluid, Body,Fluids, Body
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

T Yamamoto, and T Ogihara, and Y Kumahara, and T Hata
[Effects of angiotensin II analogue (1-sarcosine, 8-isoleucine-angiotensin II) in various types of hypertension].
March 1975, Horumon to rinsho. Clinical endocrinology,
T Yamamoto, and T Ogihara, and Y Kumahara, and T Hata
Sodium depletion and blood pressure response to 1-sarcosine, 8-isoleucine angiotensin II in hypertension.
May 1978, Clinical pharmacology and therapeutics,
T Yamamoto, and T Ogihara, and Y Kumahara, and T Hata
Effects of 1-sarcosine-8-isoleucine-angiotensin II on blood pressure and plasma renin activity in various types of hypertension.
July 1975, The Tohoku journal of experimental medicine,
T Yamamoto, and T Ogihara, and Y Kumahara, and T Hata
Blood pressure response to [1-sarcosine, 8-isoleucine] angiotensin II in patients with liver cirrhosis and ascites.
January 1979, Japanese circulation journal,
T Yamamoto, and T Ogihara, and Y Kumahara, and T Hata
Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
October 1979, Endocrinologia japonica,
T Yamamoto, and T Ogihara, and Y Kumahara, and T Hata
[Inhibiting effect of (sarcosine-1-isoleucine-8)-angiotensin II in anesthesized rats].
March 1987, Revista espanola de fisiologia,
T Yamamoto, and T Ogihara, and Y Kumahara, and T Hata
[Clinical evaluation of 1-sarcosine, 8-isoleusine angiotensin II test on renovascular hypertension (author's transl)].
February 1978, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
T Yamamoto, and T Ogihara, and Y Kumahara, and T Hata
Antagonism of peripheral and central effects of angiotensin II by (1-sarcosine, 8-isoleucine)angiotensin II.
April 1973, The Journal of pharmacology and experimental therapeutics,
T Yamamoto, and T Ogihara, and Y Kumahara, and T Hata
[Effects of sodium depletion on renal action of 1-sarcosine-8-isoleucine-angiotensin II in patients with essential hypertension (author's transl)].
August 1978, Nihon Jinzo Gakkai shi,
T Yamamoto, and T Ogihara, and Y Kumahara, and T Hata
[A case report of high plasma renin activity in chronic pulmonary disease and the effect of angiotensin-II-analogue (1-sarcosine, 8-isoleucine-angiotensin-II)].
April 1990, Nihon Kyobu Shikkan Gakkai zasshi,
Copied contents to your clipboard!